Author: OurCrowd

[NT-Tao in PR Newswire] NT-Tao raises $22M Series A to ensure a secure, clean energy future with a compact and scalable nuclear fusion solution

TEL AVIV, Israel, Feb. 1, 2023 /PRNewswire/ — NT-Tao, the nuclear fusion energy company setting a new standard for the future of clean energy, today announced that it has raised a $22M Series A round led by Delek US – a Fortune 500 downstream energy company – and NextGear Ventures, with additional participation from Honda, OurCrowd and the Grantham Foundation, the lead investor in the company’s seed round. This new funding will enable NT-Tao to continue to scale its team, accelerate prototype developments in the pipeline and build its new research facility. The latest investment round brings NT-Tao’s total funding to $28M. Read more...

Read More

[Taranis in PR Newswire] Taranis introduces AcreForward, setting a new standard for crop intelligence

WESTFIELD, Ind., Jan. 31, 2023 /PRNewswire/ — Taranis, the AI-powered crop intelligence leader, is pleased to announce the launch of AcreForward, a new offering to help ag retailers drive more value from every acre. It provides unprecedented leaf-level insights into growers’ crops at higher frequency throughout the season and captures opportunities in every acre, including new insights into soil health and carbon sequestration. Read...

Read More

[MeMed in PR Newswire] Beckman Coulter and MeMed to expand access to proven host immune response diagnostic able to distinguish between bacterial and viral infections

BREA, Calif. and HAIFA, Israel, Jan. 31, 2023 /PRNewswire/ — Beckman Coulter Diagnostics, a global leader in clinical diagnostics, and MeMed, a leader in the emerging field of advanced host-response technologies, announced today a strategic partnership to jointly develop and commercialize the proven MeMed BV® test, a host immune response diagnostic that is able to distinguish between bacterial and viral infections for use on the Access Family of Immunoassay Analyzers. Read more...

Read More